Advanced glycation end-products in chronic heart failure
PhD ceremony: Ms. S. Willemsen, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen
Title: Advanced glycation end-products in chronic heart failure
Promotor(s): prof. A.A. Voors, prof. D.J. van Veldhuisen
Faculty: Medical Sciences
The number of patients with chronic heart failure (HF) is increasing. HF is a functional cardiac disorder, impairing the ability of the ventricle to fill with or eject blood combined with symptoms of fatigue and/or breathlessness. The prognosis and quality of life are poor. In this thesis the potential role of advanced glycation end-products (AGEs; glycated proteins) accumulation in the development and progression of HF was studied. AGEs accumulate during ageing and form collagen cross links, causing stiffening of heart and vessels.
The main findings are 1) Higher levels of AGEs are associated with diastolic dysfunction; 2) Elevated AGEs levels are related to the severity of HF and its clinical outcome; 3) When used in patients with systolic HF the AGE-breaker alagebrium showed no improvement on either the exercise capacity or cardiac function. Furthermore, no changes in AGE levels were observed in the blood.
Last modified: | 13 March 2020 01.12 a.m. |
More news
-
11 February 2025
Space for your disability
When it comes to collaborations between researchers from different faculties, the UG is at the top of its game. A prime example is the Disabled City project that researches how the mobility of people with a physical disability can be explored...
-
16 January 2025
€16,5 miljoen subsidie voor onderzoek naar effect CAR T-cellen bij terugkerende beenmergkanker
Het UMCG gaat specifieke CAR-T cellen produceren om patiënten met terugkerende beenmergkanker te behandelen. Samen met Amsterdam UMC Cancer Center Amsterdam gaat het UMCG de effectiviteit van deze mogelijk nieuwe behandeling onderzoeken. Voor het...
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. Jouke de Vries, the chair of the Executive Board, looks back.